BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21500197)

  • 1. In-process crystallization of acidic drugs in acrylic microparticle systems: influence of physical factors and drug-polymer interactions.
    Alhnan MA; Basit AW
    J Pharm Sci; 2011 Aug; 100(8):3284-3293. PubMed ID: 21500197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering polymer blend microparticles: an investigation into the influence of polymer blend distribution and interaction.
    Alhnan MA; Basit AW
    Eur J Pharm Sci; 2011 Jan; 42(1-2):30-6. PubMed ID: 20950685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
    Maghsoodi M; Sadeghpoor F
    Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation.
    Sarode AL; Sandhu H; Shah N; Malick W; Zia H
    Eur J Pharm Sci; 2013 Feb; 48(3):371-84. PubMed ID: 23267847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicomechanical properties of naproxen-loaded microparticles prepared from Eudragit l100.
    Maghsoodi M
    AAPS PharmSciTech; 2009; 10(1):120-8. PubMed ID: 19184624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability.
    Onoue S; Kojo Y; Aoki Y; Kawabata Y; Yamauchi Y; Yamada S
    Drug Metab Pharmacokinet; 2012; 27(4):379-87. PubMed ID: 22240843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and Evaluation of Hot-Melt Extruded Patient-Centric Ketoprofen Mini-Tablets.
    Alshetaili AS; Almutairy BK; Tiwari RV; Morott JT; Alshehri SM; Feng X; Alsulays BB; Park JB; Zhang F; Repka MA
    Curr Drug Deliv; 2016; 13(5):730-41. PubMed ID: 26456211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers.
    Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW
    Drug Dev Ind Pharm; 2006 Jun; 32(5):569-83. PubMed ID: 16720412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.
    Chokshi RJ; Shah NH; Sandhu HK; Malick AW; Zia H
    J Pharm Sci; 2008 Jun; 97(6):2286-98. PubMed ID: 17879977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting the gastric burst release of drugs from enteric microparticles: the influence of drug molecular mass and solubility.
    Alhnan MA; Cosi D; Murdan S; Basit AW
    J Pharm Sci; 2010 Nov; 99(11):4576-83. PubMed ID: 20845456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amorphous-state characterization of efavirenz--polymer hot-melt extrusion systems for dissolution enhancement.
    Sathigari SK; Radhakrishnan VK; Davis VA; Parsons DL; Babu RJ
    J Pharm Sci; 2012 Sep; 101(9):3456-64. PubMed ID: 22437488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of burst release from pH-responsive polymeric microparticles.
    Rizi K; Green RJ; Khutoryanskaya O; Donaldson M; Williams AC
    J Pharm Pharmacol; 2011 Sep; 63(9):1141-55. PubMed ID: 21827486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and characterizations of delayed release multi particulates system of indomethacin: optimization by response surface methodology.
    Nandy BC; Mazumder B
    Curr Drug Deliv; 2014; 11(1):72-86. PubMed ID: 24783236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres.
    Rawat M; Saraf S; Saraf S
    AAPS PharmSciTech; 2007 Dec; 8(4):E116. PubMed ID: 18181537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P; Lee PI
    Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QbD-enabled systematic development of gastroretentive multiple-unit microballoons of itopride hydrochloride.
    Bansal S; Beg S; Asthana A; Garg B; Asthana GS; Kapil R; Singh B
    Drug Deliv; 2016; 23(2):437-51. PubMed ID: 24865292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
    Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
    J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melt extrusion vs. spray drying: The effect of processing methods on crystalline content of naproxen-povidone formulations.
    Haser A; Cao T; Lubach J; Listro T; Acquarulo L; Zhang F
    Eur J Pharm Sci; 2017 May; 102():115-125. PubMed ID: 28259831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ amorphisation of indomethacin with Eudragit® E during dissolution.
    Priemel PA; Laitinen R; Grohganz H; Rades T; Strachan CJ
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1259-65. PubMed ID: 24056054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.